Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 28.83 USD -2.17% Market Closed
Market Cap: 3.5B USD

Intrinsic Value

The intrinsic value of one ARQT stock under the Base Case scenario is hidden USD. Compared to the current market price of 28.83 USD, Arcutis Biotherapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARQT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Arcutis Biotherapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

ARQT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ARQT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ARQT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ARQT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Arcutis Biotherapeutics Inc.

Explain Valuation
Compare ARQT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ARQT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arcutis Biotherapeutics Inc

Current Assets 349.2m
Cash & Short-Term Investments 191.1m
Receivables 115.1m
Other Current Assets 43m
Non-Current Assets 21.8m
PP&E 5.8m
Intangibles 15.4m
Other Non-Current Assets 596k
Current Liabilities 99.8m
Accounts Payable 5.8m
Accrued Liabilities 93m
Other Current Liabilities 1m
Non-Current Liabilities 113.1m
Long-Term Debt 107.5m
Other Non-Current Liabilities 5.6m
Efficiency

Free Cash Flow Analysis
Arcutis Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arcutis Biotherapeutics Inc

Revenue
317.9m USD
Cost of Revenue
-31.9m USD
Gross Profit
286m USD
Operating Expenses
-324.3m USD
Operating Income
-38.2m USD
Other Expenses
-6.1m USD
Net Income
-44.3m USD
Fundamental Scores

ARQT Profitability Score
Profitability Due Diligence

Arcutis Biotherapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Arcutis Biotherapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ARQT Solvency Score
Solvency Due Diligence

Arcutis Biotherapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Arcutis Biotherapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARQT Price Targets Summary
Arcutis Biotherapeutics Inc

Wall Street analysts forecast ARQT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARQT is 32.26 USD with a low forecast of 29.29 USD and a high forecast of 38.85 USD.

Lowest
Price Target
29.29 USD
2% Upside
Average
Price Target
32.26 USD
12% Upside
Highest
Price Target
38.85 USD
35% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Arcutis Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARQT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ARQT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARQT stock?

The intrinsic value of one ARQT stock under the Base Case scenario is hidden USD.

Is ARQT stock undervalued or overvalued?

Compared to the current market price of 28.83 USD, Arcutis Biotherapeutics Inc is hidden .

Back to Top